Long term outcome of heart failure patients disqualified from heart transplantation

Paula Polaska1, Grazyna Jerzak-Wodzynska1, Witold Smigielski2

  • 1Heart Failure and Transplantology Department, Cardinal Stefan Wyszynski National Institute of Cardiology, Warsaw, Poland.

Acta Cardiologica
|January 12, 2021
PubMed

Insights

Patients disqualified from heart transplantation face poor survival, with a 5-year survival rate of 25%. However, specialist care and beta-blocker use improve outcomes for advanced heart failure patients.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Clinical Prognostics

Background:

  • Advanced heart failure patients have a poor prognosis.
  • Survival data for patients disqualified from heart transplantation is limited.
  • Understanding prognosis in this group is crucial for patient management.

Purpose of the Study:

  • To evaluate the long-term prognosis of patients disqualified from heart transplantation.
  • To identify factors influencing survival in patients ineligible for heart transplantation.

Main Methods:

  • Retrospective study utilizing medical records.
  • Inclusion of 151 patients disqualified from heart transplantation.
  • Long-term follow-up ranging from 0.02 to 10.1 years.

Main Results:

  • A 5-year survival rate of 25% was observed.
  • Supervision by specialist cardiology centers and beta-blocker pharmacotherapy positively impacted prognosis.
  • Renal failure, pulmonary hypertension, and liver failure were identified as negative predictors of outcome.

Conclusions:

  • Patients disqualified from heart transplantation have an unfavorable prognosis.
  • Certain factors, such as specialist care and specific pharmacotherapy, can improve survival.
  • Careful clinical assessment is vital for optimizing patient selection for heart transplantation.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
157
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
124
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
109
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
135
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
152
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.2K